News Conference News AHA 2018 EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits Michael O'Riordan November 16, 2018
News Daily News Study Questions Role of BP Meds in Patients With Hypertension but No Other CVD Risk Factors L.A. McKeown October 30, 2018
News Daily News Lack of Short-term Cancer Risk With Tainted Valsartan ‘Reassuring’ Todd Neale September 13, 2018
News Conference News ESC 2018 Weight-Loss Drug Lorcaserin Clears Cardiovascular Safety Hurdle: CAMELLIA-TIMI 61 Michael O'Riordan August 26, 2018
News Daily News In Type 2 Diabetes, Five Risk Factor Targets Keep MI, Stroke, and Death in Check Caitlin E. Cox August 15, 2018
News Industry News Medicure Announces FDA Approval of Acute Care Cardiovascular Drug Sodium Nitroprusside Injection August 14, 2018
News Daily News FDA Recalls Valsartan-Containing Drugs After Detection of Carcinogen Michael O'Riordan July 16, 2018
News Conference News EuroPCR 2018 Two Sham-Controlled Renal Denervation Studies Offer Hope in Hypertension Michael O'Riordan May 23, 2018
News Daily News Lower BP Targets Can Save Over 300,000 Lives a Year, Analysis Suggests L.A. McKeown May 23, 2018
News Daily News Time for Guidelines to Recommend ARBs Over ACE Inhibitors? Shelley Wood March 29, 2018
News Conference News ACC 2018 ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last Shelley Wood March 05, 2018
News Features Mercury Rising: As Doctors’ Groups Face Off Over BP Guidelines, Will Patients Fall Through the Cracks? L.A. McKeown February 26, 2018
News Daily News No Cardiovascular Benefit With Omega-3 Fatty Acid Supplements: Meta-analysis Michael O'Riordan February 02, 2018